TransMedics (TMDX) Accumulated Expenses (2018 - 2026)

TransMedics has reported Accumulated Expenses for 9 years, with the latest figure at $19.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 43.41% year-over-year to $19.9 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (up 43.41% YoY), and the FY2025 full-year result was $28.4 million, down 37.01% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $19.9 million, down from $28.4 million in the prior quarter.
• The five-year high for Accumulated Expenses was $56.0 million in Q3 2025, with the low at $9.8 million in Q4 2022.
• Average Accumulated Expenses over 5 years is $26.2 million, with a median of $20.2 million recorded in 2024.
• Peak annual rise in Accumulated Expenses reached 373.32% in 2022, while the deepest fall reached 39.94% in 2022.
• Tracing TMDX's Accumulated Expenses over 5 years: stood at $9.8 million in 2022, then jumped by 289.53% to $38.2 million in 2023, then climbed by 18.13% to $45.2 million in 2024, then slumped by 37.01% to $28.4 million in 2025, then plunged by 30.19% to $19.9 million in 2026.
• The last three Accumulated Expenses figures came in at $19.9 million (Q1 2026), $28.4 million (Q4 2025), and $56.0 million (Q3 2025), per Business Quant data.

Peer Comparison